AbbVie Analysts Recommendations and Consensus

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:3em;padding-top: 25px;;'>ABB</div>
ABBV -- USA Stock  

Earning Report: February 7, 2020  

The current analyst and expert consensus on AbbVie is Buy with 5 hold recommendations. The current projected target price consensus is 90.88 with 8 analysts opinions. One of the most common ways AbbVie analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to AbbVie vendors, executives, and/or customers. AbbVie recommendation module provides expert sentiment on the projected AbbVie target price to derive its highest and lowest estimates based on target price standard deviation of 8.675. Please continue to Macroaxis Advice on AbbVie to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

AbbVie Target Price Consensus

Number of Opinions10
Lowered Outlook0
Raized Outlook0
Macroaxis Recommendation   Exposure   Valuation

AbbVie Target Price Projection

Current Price

AbbVie Market Quote

Low Price87.57Odds
High Price88.53Odds


Target Price

Analyst Consensus On Target Price

Low Estimate74.0Odds
High Estimate98.0Odds
Number of Analysts8
Standard Deviation8.675


AbbVie Analysit Ratings

Average Consensus